Unpublished conference/Abstract (Scientific congresses and symposiums)
Design, synthesis and pharmacological evaluation of dimeric ligands for the benzothiadiazine dioxide allosteric binding site of the AMPA receptors
Drapier, Thomas; Francotte, Pierre; Pirotte, Bernard et al.
201529ème Journées Franco-Belge de Pharmacochimie
 

Files


Full Text
DRAPIER_présentation jfb2015final.pdf
Author postprint (8.13 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
chimie organique; pharmacologie; dimères
Abstract :
[en] L-glutamic acid is the major excitatory neurotransmitter in the brain. It exerts its effects through metabotropic and ionotropic receptors. Among the latter, three subtypes have been identified: NMDA, AMPA and KA receptors. It is now well established that a deficit in glutamatergic signaling may be responsible for neurological disorders such as schizophrenia, depression, mild cognitive impairment and ADHD. Enhancement of the signal through positive allosteric modulators of AMPA receptors might be a therapeutic issue for these diseases. These compounds are expected to exert a fine tuning of the signal. Since they require the presence of the endogenous ligand to be active, they are expected to induce less toxicity than agonists. In this context, based on the structure of known allosteric modulators of AMPA receptors such as cyclothiazide (1) and IDRA 21 (2), the Laboratory of Medicinal Chemistry (University of Liège) has developed a series of 1,2,4-benzothiadiazine 1,1-dioxides with high potency as AMPA receptor potentiators, among which compounds (3) and (4). Crystallographic data obtained by the Department of Medicinal Chemistry (University of Copenhagen) highlighted that (3) and (4) bind to two contiguous sites at the dimer interface of the ligand binding domain of the AMPA receptor1,2. From these data, we may expect that the synthesis of dimeric molecules could lead to further improvement in affinity and activity. Our work consists in the development of a family of dimeric benzothiadiazine dioxides and their evaluation in a pharmacological assay. Several structural parameters such as the position of the bridge on the aromatic ring between the two heterocycles as well as its nature and length will be studied in order to determine their impact on the activity and thus the affinity.
Research center :
Centre Interfacultaire de Recherche du Médicament - CIRM
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Drapier, Thomas ;  Université de Liège > Département de pharmacie > Chimie pharmaceutique
Francotte, Pierre  ;  Université de Liège > Département de pharmacie > Chimie pharmaceutique
Pirotte, Bernard ;  Université de Liège > Département de pharmacie > Chimie pharmaceutique
Other collaborator :
Goffin, Eric ;  Université de Liège > Département de pharmacie > Chimie pharmaceutique
Hanson, Julien  ;  Université de Liège > Département de pharmacie > Chimie pharmaceutique
Dilly, Sébastien
Kastrup, Jette;  University of Copenhagen > Faculty of Pharmaceutical Sciences > Department of Medicinal Chemistry
Language :
English
Title :
Design, synthesis and pharmacological evaluation of dimeric ligands for the benzothiadiazine dioxide allosteric binding site of the AMPA receptors
Alternative titles :
[fr] Conception et évaluation pharmacologique de ligands hautement affins pour le site allostérique des benzothiadiazines au niveau des récepteurs AMPA
Publication date :
04 June 2015
Event name :
29ème Journées Franco-Belge de Pharmacochimie
Event organizer :
ULg
Event place :
Spa, Belgium
Event date :
du 4 juin 2015 au 5 juin 2015
Audience :
International
Name of the research project :
Design, synthesis and pharmacological evaluation of dimeric ligands for the benzothiadiazine dioxide allosteric binding site of the AMPA receptors
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]
Available on ORBi :
since 05 June 2015

Statistics


Number of views
104 (13 by ULiège)
Number of downloads
2 (2 by ULiège)

Bibliography


Similar publications



Contact ORBi